BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 12529049)

  • 1. Transgenic models of tolerance and autoimmunity: with special reference to systemic lupus erythematosus.
    Ravirajan CT; Isenberg DA
    Lupus; 2002; 11(12):843-9. PubMed ID: 12529049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transgenic mice and analysis of B-cell tolerance.
    Goodnow CC
    Annu Rev Immunol; 1992; 10():489-518. PubMed ID: 1590994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of autoimmunity in a transgenic model of B cell receptor peripheral tolerance: changes in coreceptors and B cell receptor-induced tyrosine-phosphoproteins.
    Feuerstein N; Chen F; Madaio M; Maldonado M; Eisenberg RA
    J Immunol; 1999 Nov; 163(10):5287-97. PubMed ID: 10553051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoimmunity develops in lupus-prone NZB mice despite normal T cell tolerance.
    Wither J; Vukusic B
    J Immunol; 1998 Nov; 161(9):4555-62. PubMed ID: 9794382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B-cell anergy is maintained in anti-DNA transgenic NZB/NZW mice.
    Kat I; Makdasi E; Fischel R; Eilat D
    Int Immunol; 2010 Feb; 22(2):101-11. PubMed ID: 20038519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TLR9 in peritoneal B-1b cells is essential for production of protective self-reactive IgM to control Th17 cells and severe autoimmunity.
    Stoehr AD; Schoen CT; Mertes MM; Eiglmeier S; Holecska V; Lorenz AK; Schommartz T; Schoen AL; Hess C; Winkler A; Wardemann H; Ehlers M
    J Immunol; 2011 Sep; 187(6):2953-65. PubMed ID: 21859955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breakdown of self-tolerance and the pathogenesis of autoimmunity.
    Ring GH; Lakkis FG
    Semin Nephrol; 1999 Jan; 19(1):25-33. PubMed ID: 9952278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B cell autophagy mediates TLR7-dependent autoimmunity and inflammation.
    Weindel CG; Richey LJ; Bolland S; Mehta AJ; Kearney JF; Huber BT
    Autophagy; 2015; 11(7):1010-24. PubMed ID: 26120731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of B cells in systemic lupus erythematosus and rheumatoid arthritis.
    Mandik-Nayak L; Ridge N; Fields M; Park AY; Erikson J
    Curr Opin Immunol; 2008 Dec; 20(6):639-45. PubMed ID: 18775493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucocorticoid-induced leucine zipper (GILZ) inhibits B cell activation in systemic lupus erythematosus.
    Jones SA; Toh AE; Odobasic D; Oudin MA; Cheng Q; Lee JP; White SJ; Russ BE; Infantino S; Light A; Tarlinton DM; Harris J; Morand EF
    Ann Rheum Dis; 2016 Apr; 75(4):739-47. PubMed ID: 26612340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B-cell anergy: from transgenic models to naturally occurring anergic B cells?
    Cambier JC; Gauld SB; Merrell KT; Vilen BJ
    Nat Rev Immunol; 2007 Aug; 7(8):633-43. PubMed ID: 17641666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B lymphocyte selection and survival in systemic lupus.
    Liossis SN; Zouali M
    Int Arch Allergy Immunol; 2004 Jan; 133(1):72-83. PubMed ID: 14726634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transgenic models of autoimmune disease.
    Boyton RJ; Altmann DM
    Clin Exp Immunol; 2002 Jan; 127(1):4-11. PubMed ID: 11882026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T cell abnormalities in human and mouse lupus: intrinsic and extrinsic.
    Tsokos GC; Mitchell JP; Juang YT
    Curr Opin Rheumatol; 2003 Sep; 15(5):542-7. PubMed ID: 12960478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoimmunity and tolerance in Ig-transgenic mice: murine SLE as a model to study B cell tolerance.
    Tsao BP; Hahn BH
    Int Rev Immunol; 1994; 11(4):305-20. PubMed ID: 7806944
    [No Abstract]   [Full Text] [Related]  

  • 16. Upregulated Fcrl5 disrupts B cell anergy and causes autoimmune disease.
    Ono C; Tanaka S; Myouzen K; Iwasaki T; Ueda M; Oda Y; Yamamoto K; Kochi Y; Baba Y
    Front Immunol; 2023; 14():1276014. PubMed ID: 37841260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-21 receptor blockade inhibits secondary humoral responses and halts the progression of preestablished disease in the (NZB × NZW)F1 systemic lupus erythematosus model.
    Zhang M; Yu G; Chan B; Pearson JT; Rathanaswami P; Delaney J; Ching Lim A; Babcook J; Hsu H; Gavin MA
    Arthritis Rheumatol; 2015 Oct; 67(10):2723-31. PubMed ID: 26097207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-17 and the Th17 lineage in systemic lupus erythematosus.
    Garrett-Sinha LA; John S; Gaffen SL
    Curr Opin Rheumatol; 2008 Sep; 20(5):519-25. PubMed ID: 18698171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention and control of reciprocal T-B cell diversification: implications for lupus-like autoimmunity.
    Singh RR
    Mol Immunol; 2004 Feb; 40(14-15):1137-45. PubMed ID: 15036920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune tolerance to autoantibody-derived peptides delays development of autoimmunity in murine lupus.
    Singh RR; Ebling FM; Sercarz EE; Hahn BH
    J Clin Invest; 1995 Dec; 96(6):2990-6. PubMed ID: 8675671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.